Form 3 Filing for Michael Vincent Meluzio at Cue Biopharma, Inc.

This filing is a Form 3, which reports initial beneficial ownership of securities. Michael Vincent Meluzio, identified by CIK 0002138368, is the reporting owner. He is the VP, Principal Accounting Officer of Cue Biopharma, Inc. (CIK 0001645460, trading symbol CUE). The filing indicates he owns 1 security. The report of ownership is dated June 11, 2026, with the period of report being June 1, 2026. His address is listed as 40 Guest Street, Boston, MA 02135, c/o Cue Biopharma, Inc.